• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

Women with ADHD must make a difficult decision about whether to continue or stop taking ADHD medication during pregnancy and breastfeeding. There isn't much information on how long-term exposure to these medications could affect the fetus.

A recent study published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological problems such as impaired hearing or vision, febrile seizures, or IQ impairment. The authors acknowledge the need for more high-quality studies.

Risk/Benefit Analysis

Women who are pregnant and taking ADHD medications need to balance the benefits of taking them against potential risks to the foetus. Physicians do not have the data needed to make unequivocal recommendations but they can provide information on benefits and risks that can help pregnant women make informed choices.

A study published in Molecular Psychiatry concluded that women who were taking ADHD medication during early pregnancy were not at a higher risk of fetal malformations, or structural birth defects. Researchers conducted a massive population-based study of case control to compare the incidence of structural defects that were major in infants who were born to mothers who used stimulants during pregnancy. Pediatric cardiologists and clinical geneticists reviewed the cases to ensure an accurate case classification and to limit the possibility of bias.

However, the researchers' study was not without its flaws. In particular, they were not able to differentiate the effects of the medication from the effects of the underlying disorder. This makes it difficult for researchers to determine if the small associations observed among the groups that were exposed to the use of medication or affected by comorbidities. The researchers also did not look at the long-term effects for the offspring.

The study showed that infants whose mothers had taken ADHD medication during pregnancy had a slightly higher risk of admission to the neonatal care unit (NICU), compared to mothers who did not take any medication during pregnancy or had stopped taking their medication before or during pregnancy. The reason for this was central nervous system disorders. The higher risk of admission was not influenced by the stimulant medications used during pregnancy.

Women who were taking stimulant ADHD medication during pregnancy also had an increased risk of having a caesarean delivery or having a child with an low Apgar score (less than 7). These increases did appear to be unrelated to the type of medication taken during pregnancy.

Researchers suggest that the small risk of using ADHD medications during early pregnancies may be offset by the greater benefits to both mother and baby of continuing treatment for the woman's disorder. Doctors should discuss with their patients about this issue and as much as possible, assist them develop coping strategies that could reduce the impact of her disorder in her daily functioning and her relationships.

Medication Interactions

More and more doctors are faced with the decision of whether to continue treatment or stop it during pregnancy as more women are diagnosed with ADHD. These decisions are usually made without clear and authoritative evidence. Instead, doctors must take into account their own experience, the experience of other doctors and the research on the topic.

In particular, the issue of possible risks to the baby can be a challenge. The research that has been conducted on this topic is based on observation instead of controlled studies and many of the findings are in conflict. Most studies limit their analysis to live births, which may underestimate the teratogenic impact leading to terminations or abortions of pregnancy. The study discussed in this journal club addresses these issues by looking at data from both live and deceased births.

The conclusion is that while some studies have shown that there is a positive correlation between ADHD medications and the risk of certain birth defects, other studies have found no connection, and most studies demonstrate a neutral or slightly negative effect. As a result, a careful risk/benefit assessment must be conducted in every instance.

It isn't easy, but not impossible for women with ADHD to stop taking their medication. In a recent article published in Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can lead to depression and feelings of being isolated. A decrease in medication could affect the ability to drive safely and to perform work-related tasks which are crucial aspects of normal life for those with ADHD.

She suggests that women who aren't sure whether to take the medication or stop it due to their pregnancy, educate their family members, coworkers and their friends about the condition, its impact on daily functioning and the advantages of staying on the current treatment. Educating them can also make the woman feel more comfortable when she is struggling with her decision. Some medications can pass through the placenta. If a woman decides to stop taking her ADHD medication while pregnant and breastfeeding, it is important to be aware that the drug could be transferred to the baby.

Birth Defects and Risk of

As the use of ADHD medications to treat symptoms of attention deficit hyperactivity disorder (ADHD) increases, so do concerns about the effects that the drugs might have on the fetuses. A recent study published in the journal Molecular Psychiatry adds to the existing knowledge on this subject. Using two massive data sets researchers were able to look at more than 4.3 million pregnancies to determine whether the use of stimulant medications increased the risk of birth defects. Researchers discovered that although the overall risk is low, first-trimester ADHD exposure to medication was associated with slightly higher risk of certain heart defects, such as ventriculoseptal defect.

The authors of the study could not discover any connection between early medication usage and other congenital anomalies such as facial deformities or club feet. The results are in the same vein as previous studies which showed a small, but significant increase in cardiac malformations for women who began taking ADHD medication prior to the birth of their child. This risk increased in the latter half of pregnancy, as many women begin to discontinue their ADHD medications.

Women who took ADHD medication during the first trimester were more likely require a caesarean birth or have a low Apgar after delivery and had a baby that required breathing assistance at birth. However the researchers of the study were not able to eliminate selection bias by limiting the study to women who did not have other medical issues that could have contributed to these findings.

Researchers hope that their research will inform physicians when they meet pregnant women. The researchers suggest that while discussing the risks and benefits are crucial, the decision on whether to continue or stop medication should be based on the severity of each woman's ADHD symptoms and her needs.

The authors also advise that while discontinuing the medications is an option, it isn't an option that is recommended due to the high rate of depression and other mental health problems for women who are expecting or post-partum. Furthermore, research suggests that women who choose to stop their medications are more likely to have a difficult time adjusting to life without them after the baby's arrival.

Nursing

The responsibilities that come with being a new mom can be overwhelming. Women with ADHD can face severe challenges when they must deal with their symptoms, go to doctor appointments and prepare for the birth of their child and adjust to a new routine. Many women opt to continue taking their ADHD medication during pregnancy.

The risk to breastfeeding infant is not too high since the majority of stimulant medication passes through breast milk at low levels. However, the amount of uk medication for adhd exposure to the newborn may differ based on the dosage, frequency it is administered, and the time of the day the medication is administered. In addition, different medications are introduced into the baby's system via over the counter adhd medication gastrointestinal tract, or through breast milk. The impact of these medications on a newborn's health is not completely understood.

Some physicians may discontinue stimulant medication during a woman's pregnancy due to the lack of research. It's a difficult choice for the woman, who prescribes adhd medication (test.gitaransk.ru) must weigh the advantages of her medication against the risks to the fetus. In the meantime, until more information is available, doctors may ask pregnant patients if they have any history of adhd medication not working or if they intend to take medication in the perinatal stage.

Numerous studies have proven that women can continue to take their ADHD medication in a safe manner during pregnancy and while breast-feeding. As a result, an increasing number of patients opt to do this and, after consulting with their doctor, they have discovered that the benefits of continuing their current medication exceed any risk.

It is crucial for women suffering from ADHD who prescribes medication for adhd are thinking of breastfeeding to seek a specialist psychiatrist's advice prior to becoming pregnant. They should discuss their medication with their prescriber as well as the pros and cons of continuing treatment. This includes non-pharmacological methods. Psychoeducation is also necessary to help pregnant women suffering from ADHD understand the symptoms and underlying disorder. They should also be educated about treatment options and strengthen strategies for coping. This should be an approach that is multidisciplinary, including the GP doctors, obstetricians and psychiatrists. The pregnancy counselling should consist of the discussion of a treatment plan for both the mother as well as the child, as well as monitoring for signs of deterioration, and, if necessary, adjustments to the medication regimen.